Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

IK2CX001774-01
Title: Noradrenergic biomarkers in PTSD: precision medicine & mechanisms
Principal Investigator:

Rebecca Hendrickson

Location: Seattle, WA
Congressional District Code: 9
Research Service: Clinical Science R&D
Project Period: June 2018 - May 2023
FY 2021 Funding Amount: $399,589
Total Award Amount
(all years):
$2,679,743
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

Background and Study Objective: Posttraumatic stress disorder (PTSD) affects as many as 15% of service members and Veterans following deployment. Current treatments are insufficient: most medications for PTSD decrease symptom intensity only moderately, and often appear to be less effective in Veterans than civilians. Prazosin, an antagonist of one of the major receptors for noradrenaline, has demonstrated significant efficacy for particularly hyperarousal symptoms and trauma nightmares in Vetera...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.